GR1004073B - Μεθοδος παρασκευης της σιταλοπραμης - Google Patents

Μεθοδος παρασκευης της σιταλοπραμης

Info

Publication number
GR1004073B
GR1004073B GR20010100098A GR2001100098A GR1004073B GR 1004073 B GR1004073 B GR 1004073B GR 20010100098 A GR20010100098 A GR 20010100098A GR 2001100098 A GR2001100098 A GR 2001100098A GR 1004073 B GR1004073 B GR 1004073B
Authority
GR
Greece
Prior art keywords
group
compound
formula
citalopram
alkynyl
Prior art date
Application number
GR20010100098A
Other languages
English (en)
Other versions
GR20010100098A (el
Inventor
Hans Petersen
Michael Harold Rock
Haleh Ahmadian
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of GR20010100098A publication Critical patent/GR20010100098A/el
Publication of GR1004073B publication Critical patent/GR1004073B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)

Abstract

παρούσα εφεύρεση αναφέρεται σε μια μέθοδο για την παρασκευή σιταλοπράμης περιλαμβάνουσα την αντίδραση μιάς ενώσεως τύπου (Ι) με μία ένωση έχουσα τον τύπο (ΙΙ) στον οποίο το Χ είναι μια κατάλληλη αποχωριζόμενη ομάδα και το R είναι -CH2-O-Pg, -CH2-NPg1Pg2, -CH2-NMePg1, -CO-N(CH3)2, -CH(OR1)(OR2), -C(OR4)(OR5)(OR6), -COOR3, -CH2-CO-NH2, -CH=CHR7 ή -CO-NHR8 όπου το Pg είναι μία προστατευτική ομάδα μίας ομάδος αλκοόλης, τα Pg1 και Pg2 είναι προστατευτικές ομάδες μίας αμινομάδος, τα R1 και R2 επιλέγονται ανεξάρτητα απο αλκύλιο, αλκενύλιο, αλκυνύλιο και αρύλιο ή αραλκύλιο προαιρετικά υποκατασταθέν με αλκύλιο ή τα R1 και R2 σχηματίζουν ομού μία άλυσο με 2 έως 4 άτομα άνθρακα, τα R3, R4, R5, R6 και R7 επιλέγονται ανεξάρτητα απο αλκύλιο, αλκενύλιο, αλκυνύλιο και αρύλιο ή αραλκύλιο προαιρετικά υποκατασταθέν με αλκύλιο και το R8 είναι υδρογόνο ή μεθύλιο για το σχηματισμό μίας ενώσεως τύπου (ΙΙΙ) στον οποίο το R είναι όπως ορίσθηκε ανωτέρω ακολουθούμενη απο την μετατροπή της ομάδος R σε μία ομάδα διμεθυλαμινομεθυλίου και την απομόνωση της σιταλοπράμης υπό την μορφή βάσεως ή φαρμακευτικά αποδεκτού αλατός της. ΰ
GR20010100098A 2000-02-24 2001-02-22 Μεθοδος παρασκευης της σιταλοπραμης GR1004073B (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000296 2000-02-24
DKPA200000401 2000-03-13

Publications (2)

Publication Number Publication Date
GR20010100098A GR20010100098A (el) 2001-10-31
GR1004073B true GR1004073B (el) 2002-11-26

Family

ID=26068779

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100098A GR1004073B (el) 2000-02-24 2001-02-22 Μεθοδος παρασκευης της σιταλοπραμης

Country Status (26)

Country Link
US (1) US6420574B2 (el)
EP (1) EP1259501A2 (el)
JP (1) JP2003523955A (el)
KR (1) KR20020081355A (el)
CN (1) CN1608057A (el)
AR (1) AR029658A1 (el)
AU (1) AU2001235358A1 (el)
BE (1) BE1011177A6 (el)
BG (1) BG107061A (el)
BR (1) BR0108937A (el)
CA (1) CA2401236A1 (el)
EA (1) EA005315B1 (el)
FR (1) FR2805812A1 (el)
GR (1) GR1004073B (el)
HR (1) HRP20020660A2 (el)
HU (1) HUP0300212A2 (el)
IE (1) IES20010163A2 (el)
IL (1) IL151059A0 (el)
IS (1) IS6487A (el)
IT (1) ITMI20010386A1 (el)
MX (1) MXPA02008228A (el)
NL (1) NL1017415C1 (el)
NO (1) NO20023928D0 (el)
PL (1) PL363119A1 (el)
SK (1) SK13672002A3 (el)
WO (1) WO2001043525A2 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
NZ514671A (en) * 1999-04-14 2003-10-31 H Method for the preparation of citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1298124B1 (en) 1999-10-25 2007-02-28 H. Lundbeck A/S Method For the Preparation of Citalopram
US6310222B1 (en) * 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
EA004742B1 (ru) 1999-12-28 2004-08-26 Х.Лундбекк А/С Способ получения циталопрама
WO2001049672A1 (en) 1999-12-30 2001-07-12 H. Lundbeck A/S Method for the preparation of citalopram
TR200201783T2 (tr) * 2000-01-14 2002-12-23 H. Lundbeck A/S 5-Siyanofatalid hazırlamak için yöntem
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
NL1017417C1 (nl) * 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
KR20020080481A (ko) 2000-03-13 2002-10-23 하. 룬트벡 아크티에 셀스카브 시탈로프람의 제조 방법
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
CZ20023100A3 (cs) * 2000-03-13 2003-02-12 H. Lundbeck A/S Způsob výroby citalopramu
SK14512002A3 (sk) 2000-03-14 2003-03-04 H. Lundbeck A/S Spôsob výroby citalopramu, medziprodukt a citalopram výrobený týmto spôsobom
EP1274699A1 (en) * 2000-03-16 2003-01-15 H. Lundbeck A/S Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
IL144817A0 (en) 2000-08-18 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
JP3798982B2 (ja) 2000-12-22 2006-07-19 ハー・ルンドベック・アクチエゼルスカベット 純粋なシタロプラムの製造方法
AR034759A1 (es) * 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
EP1446396A1 (en) * 2001-11-08 2004-08-18 Sepracor, Inc. Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
TR200504022T1 (tr) * 2003-03-24 2006-08-21 Hetero Drugs Limited (S)-sitalopram oksalatın yeni sıvı kristal formları.
CA2575975A1 (en) * 2003-11-12 2005-05-26 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
TWI339651B (en) 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
AU2008252631B2 (en) * 2007-05-18 2012-12-20 Cipla Limited Process for the preparation of escitalopram via desmethylcitalopram, optical resolution and methylation of the S-isomer
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (el) 1965-03-18
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
US5296007A (en) 1986-11-17 1994-03-22 Ensci Inc. Process for removing sulfur from coal
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DE19626659A1 (de) 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
TR200000066T2 (tr) 1997-07-08 2000-11-21 H. Lundbeck A/S Sitalopram hazırlanması için yöntem.
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
ES2149734T3 (es) 1997-11-11 2003-02-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
PL199423B1 (pl) 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
CN1149208C (zh) 1998-12-23 2004-05-12 H.隆德贝克有限公司 制备5-氰基2-苯并[c]呋喃酮的方法
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
NZ514671A (en) 1999-04-14 2003-10-31 H Method for the preparation of citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
CH692298A5 (de) 1999-10-25 2002-04-30 Lundbeck & Co As H Verfahren zur Herstellung von Zwischenstufen für die Citalopramsynthese sowie zur Herstellung von Escitalopram.
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate

Also Published As

Publication number Publication date
JP2003523955A (ja) 2003-08-12
IS6487A (is) 2002-07-29
US20010027256A1 (en) 2001-10-04
MXPA02008228A (es) 2004-04-05
WO2001043525A3 (en) 2002-01-31
GR20010100098A (el) 2001-10-31
BE1011177A6 (fr) 2001-07-03
BR0108937A (pt) 2003-06-17
AU2001235358A1 (en) 2001-06-25
NO20023928L (no) 2002-08-19
EP1259501A2 (en) 2002-11-27
WO2001043525A2 (en) 2001-06-21
KR20020081355A (ko) 2002-10-26
NL1017415C1 (nl) 2001-05-18
IES20010163A2 (en) 2002-03-06
EA200200898A1 (ru) 2003-02-27
US6420574B2 (en) 2002-07-16
ITMI20010386A1 (it) 2002-08-26
PL363119A1 (en) 2004-11-15
EA005315B1 (ru) 2004-12-30
SK13672002A3 (sk) 2003-03-04
NO20023928D0 (no) 2002-08-19
AR029658A1 (es) 2003-07-10
BG107061A (en) 2003-05-30
FR2805812A1 (fr) 2001-09-07
CN1608057A (zh) 2005-04-20
HRP20020660A2 (en) 2004-12-31
HUP0300212A2 (hu) 2003-06-28
CA2401236A1 (en) 2001-06-21
IL151059A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
GR20010100098A (el) Μεθοδος παρασκευης της σιταλοπραμης
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
GB1472525A (en) Olefinic derivatives of amino acids
SI21463B (sl) Postopek za pripravo heksahidro-furo/2,3-b/furan-3-ola
DK57281A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater eller syreadditionssalte deraf
US4097506A (en) Cis-13,9-deoxy-PGF1 compounds
EA200000792A3 (ru) Новые пиридиновые соединения, способ их получения и содержащие их фармацевтические композиции
US4083865A (en) Inter-oxa-13,14-dihydro-PGD1 compounds
NZ521201A (en) Method for the preparation of citalopram
GB1514870A (en) Imidazolyloxime ethers having antimycotic and bactericidal activity
US4122105A (en) Cis-4,5-didehydro-12,13(E)didehydro-13,14-dihydro-PGD1 compounds
BG107050A (en) Method for the preparation of citalopram
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
ATE165810T1 (de) N-substituierte derivate des n-methyl-3-(p- trifluormethylphenoxy)-3-phenylpropylamins und verfahren zu deren herstellung
CO4700282A1 (es) Compuestos
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
KR970042447A (ko) 시클로펜타디에닐 유도체 및 이의 제조방법
SE8405514L (sv) Furyl-derivat av 16-substituerade prostaglandiner och forfarande for deras framstellning
EA199600007A3 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
IE42411B1 (en) Acetylene derivatives
HUP0004543A2 (hu) Aminopirrolin vegyületek, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
KR930017874A (ko) 포화 질소 헤테로사이클의 유도체
JPH021461A (ja) 非対称ジチオアセタール及びジチオケタールの製造方法
EA199700300A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПРАКТИЧЕСКИ ЧИСТЫХ ИЗОМЕРОВ α-БИСОКСИМОВ
IE800588L (en) Piperidinothiazolidines